Insurance Journal

OCTOBER 7, 2024

Supreme Court declined on Monday to hear former pharmaceutical company CEO Martin Shkreli’s challenge to a $64.6 million financial penalty imposed by a judge after he raised a lifesaving drug’s price by more than 4,000%. The justices turned …

Pharmaceuticals

Insurance Journal

JUNE 20, 2025

The jury found the pharmaceutical giant liable for negligence and breach of warranty, concluding that the … A Boston jury has awarded $8 million to a Massachusetts woman who developed mesothelioma after years of using Johnson & Johnson’s talcum powder products.

Pharmaceuticals

Insurance Journal

NOVEMBER 14, 2024

A jury has awarded the city of Baltimore $266 million in damages in its suit against pharmaceutical firms McKesson and AmerisourceBergen for their part in the city’s opioid epidemic. With the jury award, the city has notched another win for …

Pharmaceuticals

Insurance Journal

MAY 20, 2025

The German pharmaceutical … Bayer is preparing a plan to settle some of its mass lawsuits over Roundup weedkiller in Missouri, and may also seek bankruptcy for its Monsanto unit if the effort fails, the Wall Street Journal reported, citing sources.

Pharmaceuticals

Insurance Journal

DECEMBER 12, 2024

COLUMBUS, Ohio (AP) The Ohio Supreme Court ruled last Tuesday that the state’s product liability law prohibits counties from bringing public nuisance claims against national pharmaceutical chains as they did as part of national opioid litigation, a decision that …

Pharmaceuticals

Insurance Journal

DECEMBER 2, 2024

The province of British Columbia can bring a class action lawsuit against pharmaceutical companies for opioid harms on behalf of multiple governments across Canada, the country’s Supreme Court ruled on Friday. In 2018, BC sued more than 40 drug manufacturers, …

Pharmaceuticals

Insurance Journal

APRIL 9, 2025

Jazz Pharmaceuticals JAZZ.O said on Tuesday that it had agreed to a settlement of $145 million to resolve a series of antitrust lawsuits related to its narcolepsy drug, Xyrem. Xyrem, a medication approved in the U.S., is used for the …

Pharmaceuticals

InHouseBlog

APRIL 8, 2022

Senior Counsel – Corporate , Intact Insurance Specialty Solutions (Minneapolis, MN). Senior Director, Compliance Risk Navigation , Regeneron Pharmaceuticals (Tarrytown, NY). Director, Corporate Counsel – R&D , Regeneron Pharmaceuticals (Tarrytown, NY). Employment Counsel , Relativity Space (Long Beach, CA).

Real Estate

Insurance Journal

MAY 12, 2025

Pharmaceutical companies have agreed to pay Hawaii $700 million to settle its lawsuit over the efficacy and safety of the blood thinner Plavix, the state attorney general’s office announced. A court ruling last year ordered Bristol Myers Squibb Company and …

Pharmaceuticals

Insurance Journal

SEPTEMBER 9, 2024

Scott announced that one week before its trial is to begin, the city has reached an $80 million settlement with Teva Pharmaceuticals to resolve the city’s claims over the firm’s role in fueling Baltimore’s opioid epidemic. Mayor Brandon M. Teva …

Pharmaceuticals

Insurance Journal

AUGUST 8, 2024

The third trial over claims that discontinued heartburn drug Zantac ended in a mistrial on Wednesday when jurors could not agree about whether pharmaceutical company Boehringer Ingelheim was responsible for an Illinois man’s cancer. Martin Gross alleged in his lawsuit …

Pharmaceuticals

Securities Docket

SEPTEMBER 17, 2024

Source: Litigation Team of Jason Halper and Sara (Bussiere) Brauerman Join Vinson & Elkins in New York | Vinson & Elkins LLP

Litigation

Complex Discovery

OCTOBER 15, 2024

These enforcement actions targeted critical sectors, including pharmaceuticals, healthcare, technology, and energy. Banking and insurance, as well as manufacturing, each represented 10.3% Energy and natural resources accounted for 7.1% , followed by chemicals and pharmaceuticals at 4.8%. of the total​.

Pharmaceuticals

IP Watchdog

JULY 22, 2024

Pharmacy benefit managers, or simply PBMs, are often owned by either the pharmacies themselves or sometimes by insurers, which creates a lot of self-dealing to say the least. These PBMs are middlemen who receive 50% of the value of the drug, significantly raising drug prices. This has nothing to do with IP whatsoever.

Insurance

Forensic Psychologist

JANUARY 1, 2016

The solipsist premise of Peter Weir’s 1998 Truman Show , starring Jim Carrey as an insurance adjuster who realizes that his entire life is actually a TV show, was not original. The psychiatric patient in Robert Heinlein’s 1941 short story, “ They— ,” was convinced that he was an actor on a stage; the troubled protagonist of Philip K.

Construction

Insurance Journal

SEPTEMBER 15, 2024

Walgreens Boots Alliance agreed to pay $106.8 million to settle charges it fraudulently billed the U.S. government for prescriptions that were never dispensed, the Department of Justice said on Friday. The Justice Department said Walgreens violated the federal False Claims …

Pharmaceuticals

Insurance Journal

JANUARY 14, 2025

Dermatologicals, which include a number of high-priced, private label drugs, account for the biggest share of the total drug spend in the California workers’ compensation system, a new report shows. Data from the California Workers’ Compensation Institute shows recent shifts …

Pharmaceuticals

Insurance Journal

OCTOBER 7, 2024

Migraine drugs represent a small percentage of prescriptions dispensed to injured workers in California, but they make up a larger share of workers’ compensation drug payments, a new report shows. Fewer than 1% of all prescriptions dispensed to injured California …

Pharmaceuticals

Insurance Journal

JANUARY 20, 2025

The Department of Justice sued Walgreens Boots Alliance Inc. for allegedly dispensing opioids and other controlled substances at pharmacies across the US while ignoring red flags that the prescriptions were likely illegal. The lawsuit claims Walgreens pharmacists filled millions of …

Pharmaceuticals

Insurance Journal

APRIL 24, 2025

Eli Lilly said Wednesday it had sued four compounders for selling unapproved products containing tirzepatide, after a U.S. judge last month blocked pharmacies from making copies of its weight-loss and diabetes medicines. Compounders were, until recently, allowed to produce copies …

Pharmaceuticals

Insurance Journal

APRIL 21, 2025

Walgreens has agreed to pay $300 million to settle U.S. prosecutors’ allegations that it illegally filled millions of invalid prescriptions for opioids and other controlled substances, the U.S. Justice Department said on Monday. The money, plus 4% interest annually, will …

Pharmaceuticals